BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 437261)

  • 1. Stereospecific binding of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat brain dopamine receptors [proceedings].
    Davis A; Poat JA; Woodruff GN
    Biochem Soc Trans; 1979 Feb; 7(1):147-8. PubMed ID: 437261
    [No Abstract]   [Full Text] [Related]  

  • 2. ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene): a prototype for possible dopaminergic false transmitters?
    Roberts PJ; Davis A
    Adv Biochem Psychopharmacol; 1978; 19():177-91. PubMed ID: 696460
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of a conformationally restricted dopamine analogue, 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, to receptors on rat brain synaptic membranes.
    Roberts PJ; Woodruff GN; Poat JA
    Mol Pharmacol; 1977 May; 13(3):541-7. PubMed ID: 17829
    [No Abstract]   [Full Text] [Related]  

  • 4. Binding of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat brain synaptic membranes: association with the dopamine (3,4-dihydroxyphenethylamine) receptor.
    Roberts PJ; Woodruff GN; Poat JA
    Biochem Soc Trans; 1976; 4(2):316-7. PubMed ID: 1001677
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) as a ligand for brain dopamine receptors [proceedings].
    Cross AJ; Crow TJ; Owen F
    Br J Pharmacol; 1979 May; 66(1):87P. PubMed ID: 454971
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in (3H)-ADTN binding to microsomal and synaptic membrane fractions from rat striata following kainic acid lesions.
    Davis A; Woodruff GN; Poat JA; Freedman SB
    Biochem Pharmacol; 1980 Jun; 29(12):1645-8. PubMed ID: 7406893
    [No Abstract]   [Full Text] [Related]  

  • 7. Binding of [3H]amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat striatal membranes. Effects of purine nucleotides and ultraviolet irradiation.
    Zahniser NR; Heidenreich KA; Molinoff PB
    Mol Pharmacol; 1981 May; 19(3):372-8. PubMed ID: 7266464
    [No Abstract]   [Full Text] [Related]  

  • 8. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
    Clement-Cormier Y; Abel M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor binding of 3H-ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) regulated by guanyl nucleotides.
    Creese I; Snyder SH
    Eur J Pharmacol; 1978 Aug; 50(4):459-61. PubMed ID: 699970
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in guanine nucleotide sensitive and insensitive 3H-ADTN binding in striatum following substantia nigra lesions.
    Hirschhorn ID; Makman MH; Gardner EL
    Eur J Pharmacol; 1980 Mar; 62(1):123-4. PubMed ID: 6154585
    [No Abstract]   [Full Text] [Related]  

  • 11. Binding of [3H]sulpiride to purified rat striatal synaptic membranes.
    Woodruff GN; Freedman SB
    Neuroscience; 1981; 6(3):407-10. PubMed ID: 7219722
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine receptor binding regulated by guanine nucleotides.
    Creese I; Usdin TB; Snyder SH
    Mol Pharmacol; 1979 Jul; 16(1):69-76. PubMed ID: 481426
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices.
    Mulder AH; Braakhuis B; De Regt V; Dijkstra D; Horn AS
    Eur J Pharmacol; 1980 Jun; 64(4):349-55. PubMed ID: 7389827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective reduction of one class of dopamine receptor binding sites in the corpus striatum of aged rats.
    De Blasi A; Mennini T
    Brain Res; 1982 Jun; 242(2):361-4. PubMed ID: 7116143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation by ascorbic acid of dopamine agonist and antagonist binding sites in striatum.
    Kayaalp SO; Neff NH
    Life Sci; 1980 Jun; 26(22):1837-41. PubMed ID: 7401904
    [No Abstract]   [Full Text] [Related]  

  • 17. Retina contains guanine nucleotide sensitive and insensitive classes of dopamine receptors.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Eur J Pharmacol; 1980 May; 63(2-3):217-22. PubMed ID: 6155277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats.
    Pycock CJ; Kerwin RW; Carter CJ
    Nature; 1980 Jul; 286(5768):74-6. PubMed ID: 7393327
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.
    Boehme RE; Ciaranello RD
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3255-9. PubMed ID: 6166945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex.
    Marchais D; Tassin JP; Bockaert J
    Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.